Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CMED Partners appears to be a private Colorado limited-liability limited partnership rather than an operating biotech, pharma, or healthcare company. Publicly available records identify it as "CMED PARTNERS LLLP," formed in Colorado on February 27, 1991, with a registered office in Englewood, Colorado and current good-standing status. The entity shows up primarily in business-registry and SEC ownership filings, including disclosures related to holdings in medical device company Encision, which suggests it functions as an investment or holding vehicle. There is no clear evidence from public sources that CMED Partners develops therapeutics, operates a clinical pipeline, or provides life-science products or services directly. As a result, it is best classified as a non-operating investment entity with healthcare-adjacent ownership activity rather than a life sciences operating company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CMED Partners.